Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring <i>ROS1</i> Rearrangement
PaperCitations, authors & open-access status
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring <i>ROS1</i> Rearrangement is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 298 citations, 2017 year and green oa status.
298
Citations
2017
Year
green
OA Status